Oral Suspension
May 23, 2012 at 12:21 | Source: Moneycontrol.com
Feb 06, 2008 at 19:20
Jul 20, 2007 at 15:07
Apr 12, 2007 at 14:51
Feb 03, 2007 at 11:31
Photos »
/ 
News across the web »
May 25, 2012 at 22:26 | Source: FirstPost
Feb 18, 2012 at 23:16 | Source: Forbes
Interact & exchange stock tips & market info »
Related News »
(RTTNews) - Manufacturer of generic pharmaceuticals and active pharmaceutical ingredients Aurobindo Pharma Ltd. said it had received final approval for its tentatively approved ANDAs for Nevirapine tablets 200mg covered under ANDA 077521 and Nevirapine ...
May 23, 2012 at 06:33 | Source: RTT News
Literature suggests that concomitant use of PPIs with Methotrexate (primarily at high dose; see Methotrexate prescribing information) may elevate and prolong serum levels of Methotrexate and/or its metabolite, possibly leading to Methotrexate ...
May 15, 2012 at 18:31 | Source: Center for Food Safety and Applied Nutrition
Mumbai, May 23 : Aurobindo Pharma today said it has received the final approval from the US Food and Drug Administration (USFDA) for Neviraping Tablets and Neviraping Oral Suspension. The products have a market size of approximately USD 125 million for the ...
May 24, 2012 at 08:27 | Source: New Kerala
New Delhi: Aurobindo Pharma today said it has received final approval from the US health regulator for its generic Nevirapine tablets and oral suspension used for treating human immunodeficiency virus (HIV). The company has received final ...
May 25, 2012 at 04:51 | Source: zeenews.india.com
The WARNINGS AND PRECAUTIONS section of the Zmax drug label (azithromycin extended release for oral suspension) was revised in March 2012 to include new information regarding risk for QT interval prolongation, which appears to be low. The drug labels for ...
May 17, 2012 at 19:55 | Source: Center for Food Safety and Applied Nutrition
Bonsai Pharma for Orlin Suspension, Karnatak Antibiotics & Pharmaceutical Ltd for Slow Diclofenac tablets BP 100 mg, Akums Drugs & Pharmaceutical Ltd. for amoxycillin and potassium clavunate oral suspension and Hiral Labs Ltd. for Hizyme-B-a powerful ...
May 22, 2012 at 02:17 | Source: pharmabiz.com
Want to see more news summaries? Sign up for AHIP Solutions SmartBrief AHIP Solutions SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news ...
May 24, 2012 at 13:49 | Source: SmartBrief
The Warnings and Precautions section of the Zmax drug label (azithromycin extended-release for oral suspension) was revised in March 2012 to include new information regarding risk for QT interval prolongation, which appears to be low. The drug labels for ...
May 17, 2012 at 23:58 | Source: Monthly Prescribing Reference
According to the agency, the “Warnings and Precautions” section of the Zmax drug label (azithromycin extended release for oral suspension) was revised in March 2012 to include new information regarding risk for QT interval prolongation.
May 18, 2012 at 14:10 | Source: Newsinferno.com